This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vantive US Healthcare LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Federal Supply Schedule 65 IB. With a potential value of $25,000 and a period of performance through August 2024, this multiple-award schedule aims to ensure Veterans receive needed medical supplies and treatments. The...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to TG Therapeutics Inc. The contract provides pharmaceuticals and drugs under GSA Schedule 65 IB, which covers drugs, pharmaceuticals, and hematology related products. With a potential value of $20 million and a period of performance through August 2026, this multiple-award contract aims to procure these medical supplies for VA healthcare...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to QED Therapeutics, Inc. for pharmaceuticals and drugs under GSA Schedule 65 IB. With a potential value of $2,038,200 and a period of performance through September 15, 2022, this multiple award IDV aims to procure various drugs, pharmaceuticals, and hematology-related products for VA medical facilities within the specified network. The...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to Vivus LLC. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS Contract 65 I B, with a period of performance from May 1, 2019 to January 31, 2026 and a ceiling value of $5,316,660.00. The contract was awarded as a multiple-award Federal Supply Schedule, meaning Vivus LLC...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to provide drugs, pharmaceuticals, and hematology-related products to VHA facilities. The prime contractor is Nabriva Therapeutics US Inc., a for-profit organization. The contract has a potential value of $225,000 and a period of performance through October 15, 2023. No set-asides were used in the...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for VHA facilities. The prime contractor is Vyne Pharmaceuticals Inc., doing business as Menlo Therapeutics, with a potential value of $225,000 over the period of performance from August 2020 through August 2022. The contract was...